Fig. 5From: Data quality considerations for evaluating COVID-19 treatments using real world data: learnings from the National COVID Cohort Collaborative (N3C)Standardized mean differences between patient characteristics, pandemic timing, and data partner ID, for patients with and without prior history. The largest differences are observed for chronic conditions and their treatments. Missing demographic information such as race and ethnicity also display large differencesBack to article page